66 related articles for article (PubMed ID: 18796321)
1. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
2. Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.
Rinaldi A; Dumas F; Duskey JT; Imbriano C; Belluti S; Roy C; Ottonelli I; Vandelli MA; Ruozi B; Garcion E; Tosi G; Boury F
Int J Pharm; 2024 Apr; 654():123994. PubMed ID: 38484859
[TBL] [Abstract][Full Text] [Related]
3. Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells.
Martino S; di Girolamo I; Tiribuzi R; D'Angelo F; Datti A; Orlacchio A
J Biomed Biotechnol; 2009; 2009():410260. PubMed ID: 19503805
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in Mouse Brain.
Nikan M; Osborn MF; Coles AH; Biscans A; Godinho BMDC; Haraszti RA; Sapp E; Echeverria D; DiFiglia M; Aronin N; Khvorova A
Bioconjug Chem; 2017 Jun; 28(6):1758-1766. PubMed ID: 28462988
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid-siRNA conjugates.
Salim L; Islam G; Desaulniers JP
Nucleic Acids Res; 2020 Jan; 48(1):75-85. PubMed ID: 31777918
[TBL] [Abstract][Full Text] [Related]
6. A combinatorial approach for achieving CNS-selective RNAi.
Ferguson CM; Godinho BMDC; Echeverria D; Hassler M; Vangjeli L; Sousa J; McHugh N; Alterman J; Hariharan V; Krishnamurthy PM; Watts J; Rogaev E; Khvorova A
Nucleic Acids Res; 2024 May; 52(9):5273-5284. PubMed ID: 38348876
[TBL] [Abstract][Full Text] [Related]
7. Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo.
Hassler MR; Turanov AA; Alterman JF; Haraszti RA; Coles AH; Osborn MF; Echeverria D; Nikan M; Salomon WE; Roux L; Godinho BMDC; Davis SM; Morrissey DV; Zamore PD; Karumanchi SA; Moore MJ; Aronin N; Khvorova A
Nucleic Acids Res; 2018 Mar; 46(5):2185-2196. PubMed ID: 29432571
[TBL] [Abstract][Full Text] [Related]
8. Transferrin-Dressed Virus-like Ternary Nanoparticles with Aggregation-Induced Emission for Targeted Delivery and Rapid Cytosolic Release of siRNA.
Zhang T; Guo W; Zhang C; Yu J; Xu J; Li S; Tian JH; Wang PC; Xing JF; Liang XJ
ACS Appl Mater Interfaces; 2017 May; 9(19):16006-16014. PubMed ID: 28447465
[TBL] [Abstract][Full Text] [Related]
9. Improvement of DNA Vector Delivery of DOTAP Lipoplexes by Short-Chain Aminolipids.
Buck J; Mueller D; Mettal U; Ackermann M; Grisch-Chan HM; Thöny B; Zumbuehl A; Huwyler J; Witzigmann D
ACS Omega; 2020 Sep; 5(38):24724-24732. PubMed ID: 33015490
[TBL] [Abstract][Full Text] [Related]
10. Catalytic self-assembly of a DNA dendritic complex for efficient gene silencing.
Lv Y; Peng R; Zhou Y; Zhang X; Tan W
Chem Commun (Camb); 2016 Jan; 52(7):1413-5. PubMed ID: 26626818
[TBL] [Abstract][Full Text] [Related]
11. Tunable diblock copolypeptide hydrogel depots for local delivery of hydrophobic molecules in healthy and injured central nervous system.
Zhang S; Anderson MA; Ao Y; Khakh BS; Fan J; Deming TJ; Sofroniew MV
Biomaterials; 2014 Feb; 35(6):1989-2000. PubMed ID: 24314556
[TBL] [Abstract][Full Text] [Related]
12. Cellular targets for influenza drugs.
Min JY; Subbarao K
Nat Biotechnol; 2010 Mar; 28(3):239-40. PubMed ID: 20212486
[No Abstract] [Full Text] [Related]
13. Lipid-based nanoparticles and RNA as innovative neuro-therapeutics.
Tsakiri M; Zivko C; Demetzos C; Mahairaki V
Front Pharmacol; 2022; 13():900610. PubMed ID: 36016560
[TBL] [Abstract][Full Text] [Related]
14. Non-viral vectors for RNA delivery.
Yan Y; Liu XY; Lu A; Wang XY; Jiang LX; Wang JC
J Control Release; 2022 Feb; 342():241-279. PubMed ID: 35016918
[TBL] [Abstract][Full Text] [Related]
15. Non-viral Vector Mediated RNA Interference Technology for Central Nerve System Injury.
Macks C; Lee JS
DNA RNA Nanotechnol; 2016; 3(1):14-22. PubMed ID: 34970631
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach.
Coutinho MF; Santos JI; S Mendonça L; Matos L; Prata MJ; S Jurado A; Pedroso de Lima MC; Alves S
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785133
[TBL] [Abstract][Full Text] [Related]
17. The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview.
Anauate AC; Leal MF; Calcagno DQ; Gigek CO; Karia BTR; Wisnieski F; Dos Santos LC; Chen ES; Burbano RR; Smith MAC
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150871
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of protein kinase N3 small interfering RNA and doxorubicin combination therapy on liver and lung metastases.
Hattori Y; Kikuchi T; Nakamura M; Ozaki KI; Onishi H
Oncol Lett; 2017 Nov; 14(5):5157-5166. PubMed ID: 29098022
[TBL] [Abstract][Full Text] [Related]
19. Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System.
Tan JY; Sellers DL; Pham B; Pun SH; Horner PJ
Front Mol Neurosci; 2016; 9():108. PubMed ID: 27847462
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
